Clarus (CRXT) PT Slashed to $3 at Needham & Company on "Significant Financing Overhang" May 17, 2022 06:39AM
Clarus (CRXT) PT Lowered to $8 at Needham & Company Mar 31, 2022 07:00AM
UPDATE: Needham & Company Starts Clarus (CRXT) at Buy Oct 6, 2021 06:03AM
Clarus Therapeutics Closes Transaction With Blue Water, Debuts as a Publicly Traded Company to Develop Androgen and Metabolic Therapies Sep 9, 2021 12:46PM